Literature DB >> 23356456

Bronchoalveolar lavage as a tool to predict, diagnose and understand bronchiolitis obliterans syndrome.

V E Kennedy1, J L Todd, S M Palmer.   

Abstract

Bronchiolitis obliterans syndrome (BOS), a condition of irreversible small airway fibrosis, is the principal factor limiting long-term survival after lung transplantation. Bronchoscopy and bronchoalveolar lavage (BAL), techniques central to lung transplant clinical practice, provide a unique opportunity to interrogate the lung allograft during BOS development and identify potential disease mechanisms or biomarkers. Over the past 20 years, numerous studies have evaluated the BAL cellular composition, cytokine profiles and protein constituents in lung transplant recipients with BOS. To date, however, no summative evaluation of this literature has been reported. We developed and applied objective criteria to qualitatively rank the strength of associations between BAL parameters and BOS in order to provide a comprehensive and systematic assessment of the literature. Our analysis indicates that several BAL parameters, including neutrophil count, interleukin-8, alpha defensins and MMP-9, demonstrate highly replicable associations with BOS. Additionally, we suggest that considerable opportunity exists to increase the knowledge gained from BAL analyses in BOS through increased sample sizes, covariant adjustment and standardization of the BAL technique. Further efforts to leverage analysis of BAL constituents in BOS may offer great potential to provide additional in-depth and mechanistic insights into the pathogenesis of this complex disease. © Copyright 2013 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23356456      PMCID: PMC3582805          DOI: 10.1111/ajt.12091

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  112 in total

1.  Elevated levels of interleukin-8 and transforming growth factor-beta in bronchoalveolar lavage fluid from patients with bronchiolitis obliterans syndrome: proinflammatory role of bronchial epithelial cells. Munich Lung Transplant Group.

Authors:  A Elssner; F Jaumann; S Dobmann; J Behr; M Schwaiblmair; H Reichenspurner; H Fürst; J Briegel; C Vogelmeier
Journal:  Transplantation       Date:  2000-07-27       Impact factor: 4.939

2.  Bile acids aspiration reduces survival in lung transplant recipients with BOS despite azithromycin.

Authors:  V Mertens; K Blondeau; L Van Oudenhove; B Vanaudenaerde; R Vos; R Farre; A Pauwels; G Verleden; D Van Raemdonck; D Sifrim; L J Dupont
Journal:  Am J Transplant       Date:  2011-02       Impact factor: 8.086

3.  Neutrophils, unopposed neutrophil elastase, and alpha1-antiprotease defenses following human lung transplantation.

Authors:  K C Meyer; D R Nunley; J H Dauber; A T Iacono; R J Keenan; R D Cornwell; R B Love
Journal:  Am J Respir Crit Care Med       Date:  2001-07-01       Impact factor: 21.405

4.  Registry of the International Society for Heart and Lung Transplantation: twenty-fifth official adult lung and heart/lung transplantation report--2008.

Authors:  Jason D Christie; Leah B Edwards; Paul Aurora; Fabienne Dobbels; Richard Kirk; Axel O Rahmel; David O Taylor; Anna Y Kucheryavaya; Marshall I Hertz
Journal:  J Heart Lung Transplant       Date:  2008-09       Impact factor: 10.247

5.  Longitudinal comparisons of lymphocytes and subtypes between airway wall and bronchoalveolar lavage after human lung transplantation.

Authors:  Ling Zheng; Bernadette Orsida; Helen Whitford; Bronwyn Levvey; Chris Ward; E Haydn Walters; Trevor J Williams; Gregory I Snell
Journal:  Transplantation       Date:  2005-07-27       Impact factor: 4.939

6.  Critical role for the chemokine MCP-1/CCR2 in the pathogenesis of bronchiolitis obliterans syndrome.

Authors:  J A Belperio; M P Keane; M D Burdick; J P Lynch; Y Y Xue; A Berlin; D J Ross; S L Kunkel; I F Charo; R M Strieter
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

7.  Airway neutrophilia in stable and bronchiolitis obliterans syndrome patients following lung transplantation.

Authors:  L Zheng; E H Walters; C Ward; N Wang; B Orsida; H Whitford; T J Williams; T Kotsimbos; G I Snell
Journal:  Thorax       Date:  2000-01       Impact factor: 9.139

8.  Peaks of transforming growth factor-beta mRNA in alveolar cells of lung transplant recipients as an early marker of chronic rejection.

Authors:  J M Charpin; J Valcke; L Kettaneh; B Epardeau; M Stern; D Israël-Biet
Journal:  Transplantation       Date:  1998-03-15       Impact factor: 4.939

9.  Cytokine gene transcripts for tumor necrosis factor-alpha, interleukin-2, and interferon-gamma in human pulmonary allografts.

Authors:  S Sundaresan; Y G Alevy; N Steward; J Tucker; E P Trulock; J D Cooper; G A Patterson; T Mohanakumar
Journal:  J Heart Lung Transplant       Date:  1995 May-Jun       Impact factor: 10.247

10.  Are multiple immunopathogenetic events occurring during the development of obliterative bronchiolitis and acute rejection?

Authors:  N L Reinsmoen; R M Bolman; K Savik; K Butters; M I Hertz
Journal:  Transplantation       Date:  1993-05       Impact factor: 4.939

View more
  23 in total

1.  Parametric response mapping as an indicator of bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation.

Authors:  Craig J Galbán; Jennifer L Boes; Maria Bule; Carrie L Kitko; Daniel R Couriel; Timothy D Johnson; Vihba Lama; Eef D Telenga; Maarten van den Berge; Alnawaz Rehemtulla; Ella A Kazerooni; Michael J Ponkowski; Brian D Ross; Gregory A Yanik
Journal:  Biol Blood Marrow Transplant       Date:  2014-06-18       Impact factor: 5.742

Review 2.  Chronic lung allograft dysfunction phenotypes and treatment.

Authors:  Stijn E Verleden; Robin Vos; Bart M Vanaudenaerde; Geert M Verleden
Journal:  J Thorac Dis       Date:  2017-08       Impact factor: 2.895

3.  Bronchiolitis obliterans syndrome susceptibility and the pulmonary microbiome.

Authors:  Cody Schott; S Samuel Weigt; Benjamin A Turturice; Ahmed Metwally; John Belperio; Patricia W Finn; David L Perkins
Journal:  J Heart Lung Transplant       Date:  2018-04-26       Impact factor: 10.247

4.  The Diacetyl-Exposed Human Airway Epithelial Secretome: New Insights into Flavoring-Induced Airways Disease.

Authors:  David M Brass; William M Gwinn; Ashlee M Valente; Francine L Kelly; Christie D Brinkley; Andrew E Nagler; M Arthur Moseley; Daniel L Morgan; Scott M Palmer; Matthew W Foster
Journal:  Am J Respir Cell Mol Biol       Date:  2017-06       Impact factor: 6.914

5.  Pediatric lung transplantation: Dynamics of the microbiome and bronchiolitis obliterans in cystic fibrosis.

Authors:  Ahmed A Metwally; Christian Ascoli; Benjamin Turturice; Asha Rani; Ravi Ranjan; Yang Chen; Cody Schott; Albert Faro; Thomas W Ferkol; Patricia W Finn; David L Perkins
Journal:  J Heart Lung Transplant       Date:  2020-05-19       Impact factor: 10.247

6.  Evaluation of nasal fluid β-defensin 2 levels in children with allergic rhinitis.

Authors:  Fatih Dilek; Özkaya Emin; Bilge Gültepe; Mebrure Yazıcı; Erkan Çakır; Ahmet Hakan Gedik
Journal:  Turk Pediatri Ars       Date:  2017-06-01

7.  Bronchoalveolar bile acid and inflammatory markers to identify high-risk lung transplant recipients with reflux and microaspiration.

Authors:  Chen Yang Kevin Zhang; Musawir Ahmed; Ella Huszti; Liran Levy; Sarah E Hunter; Kristen M Boonstra; Sajad Moshkelgosha; Andrew T Sage; Sassan Azad; Ricardo Zamel; Rasheed Ghany; Jonathan C Yeung; Oscar M Crespin; Courtney Frankel; Marie Budev; Pali Shah; John M Reynolds; Laurie D Snyder; John A Belperio; Lianne G Singer; S Samuel Weigt; Jamie L Todd; Scott M Palmer; Shaf Keshavjee; Tereza Martinu
Journal:  J Heart Lung Transplant       Date:  2020-05-19       Impact factor: 10.247

8.  Hyaluronan contributes to bronchiolitis obliterans syndrome and stimulates lung allograft rejection through activation of innate immunity.

Authors:  Jamie L Todd; Xingan Wang; Seichiro Sugimoto; Vanessa E Kennedy; Helen L Zhang; Elizabeth N Pavlisko; Fran L Kelly; Howard Huang; Daniel Kreisel; Scott M Palmer; Andrew E Gelman
Journal:  Am J Respir Crit Care Med       Date:  2014-03-01       Impact factor: 21.405

9.  Amphiregulin contributes to airway remodeling in chronic allograft dysfunction after lung transplantation.

Authors:  Jamie L Todd; Fran L Kelly; Andrew Nagler; Kane Banner; Elizabeth N Pavlisko; John A Belperio; David Brass; S Sam Weigt; Scott M Palmer
Journal:  Am J Transplant       Date:  2019-12-01       Impact factor: 8.086

10.  Circulating exosomes with lung self-antigens as a biomarker for chronic lung allograft dysfunction: A retrospective analysis.

Authors:  Monal Sharma; Muthukumar Gunasekaran; Ranjithkumar Ravichandran; Cynthia E Fisher; Ajit P Limaye; Chengcheng Hu; John McDyer; Vaidehi Kaza; Ankit Bharat; Sofya Tokman; Ashraf Omar; Ashwini Arjuna; Rajat Walia; Ross M Bremner; Michael A Smith; Ramsey R Hachem; Thalachallour Mohanakumar
Journal:  J Heart Lung Transplant       Date:  2020-07-07       Impact factor: 10.247

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.